Chinese herbal medicines for treating skin and soft-tissue infections

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 7, 2014, Pages

  Wang, Yun Fei ^a   Que, Hua Fa ^a   Wang, Yong Jun ^a   Cui, Xue Jun ^a  

^a LONGHUA HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT;

BIBLIOGRAPHIC DATABASE; COMPARATIVE STUDY; HUMAN; MEDICAL INFORMATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTER; REVIEW; RISK BENEFIT ANALYSIS; SKIN INFECTION; SOFT TISSUE INFECTION; SYSTEMATIC REVIEW; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS;

DRUGS, CHINESE HERBAL; HUMANS; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS;

EID: 84922391571     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010619.pub2     Document Type: Review

References (64)

1. Chen ZH, Chen K. Effect of therapy with traditional Chinese medicine, acupuncture and antibiotic on patients with periappendicural abscess. Modern Journal of Integrated Traditional Chinese and Western Medicine 2007;16(19):2682-3.
2. Gao L, Xu GX, Zhou HB. Efficacy evaluation of diabetic foot ulceration treated with iodophors dressings therapy. Journal of Clinical Nursing 2007;6(4):21-2.
3. Hirsch T, Ashkar W, Schumacher O, Steinstraesser L, Ingianni G, Cedidi C. Moist Exposed Burn Ointment (MEBO) in partial thickness burns - a randomized, comparative open mono-center study on the efficacy of dermaheal (MEBO) ointment on thermal 2nd degree burns compared to conventional therapy. European Journal of Medical Research 2008;13(11):505-10.
4. Leung PC, Pang SY, Wong ELY, Cheng KF. Inflammatory state of type II diabetic patients with chronic ulcers in response to herbal treatment. Foot (Edinburgh, Scotland) 2012;22(3):181-5.
5. Panahi Y, Beiraghdar F, Akbari H, Bekhradi H, Taghizadeh M, Sahebkar A. A herbal cream consisting of Aloe vera, Lavandulastoechas and Pelargonium roseum as an alternative for silver sulfadiazine in burn management. Asian Biomedicine 2012;6(2):273-8.
6. Wang C, Lu JG, Cao YQ, Yao YB, Guo XT, Yin HQ. Traditional Chinese surgical treatment for anal fistulae with secondary tracks and abscess. World Journal of Gastroenterology 2012;18(40):5702-8.
7. Wei Q, Yao C. The distribution of microorganism of the wound on the treatment of chronic lower leg ulcer patients with Traditional Chinese Medicine of Shengji Yuhong Gao: A 257 cases of multicenter, double-blinded RCT. Clinical Dermatology 2013;42(8):497-500.
8. Ye MN, Chen HF, Cheng YQ, Zhang YS, Li P, Gui G, et al.Study protocol for a self-controlled case study to evaluate the safety and standardization for external application of Chinese medicine Jiuyi Powder. Zhong xi yi jie he xue bao [Journal of Chinese integrative medicine] 2011;9(11):1199-205.
9. Zhang X-J, Yan M, Liu Y, Wang X-M, Nuriding H. Effects of Huangqi injection on infection factors in children with acute lymphoblastic leukemia. Chinese Journal of Contemporary Pediatrics 2014;16(2):147-51.
10. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences of the United States of America 1999;96:1152-6.
11. Behera B, Bhoriwal S, Mathur P, Sagar S, Singhal M, Misra MC. Post-traumatic skin and soft tissue infection due to Aeromonas hydrophila. Indian Journal of Critical Care Medicine 2011;15(1):49-51.
12. British Lymphology Society (BLS). Consensus document on the management of cellulitis in lymphoedema. http://www.thebls.com/consensus.php (accessed 2013).
13. Bounthavong M, Hsu DI. Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis. Current Medical Research and Opinion 2010;26(2):407-21.
14. Chen ML, Hao Z, Tian Y, Zhang QY, Gao PJ, Jin JL. Different effects of six antibiotics and ten traditional Chinese medicines on Shiga toxin expression by Escherichia coli O157:H7. Evidence-Based Complementary and Alternative Medicine 2013 Jan;2013:1-8 http://dx.doi.org/10.1155/2013/121407.
15. Cheng JT. Review: drug therapy in Chinese Traditional Medicine. Journal of Clinical Pharmacology 2000;40:445-50.
16. Collins RA. A ten-year audit of traditional Chinese medicine and other natural product research published in the Chinese Medical Journal (2000-2009). Chinese Medical Journal (English) 2011;124(9):1401-8.
17. Chinese Pharmacopoeia Commission (CPC). Pharmacopoeia of the People's Republic of China. Vol. 1, Beijing: China Medical Science and Technology Publishing House, 2010.
18. Clinical Resource Efficiency Support Team (CREST). Guidelines on the management of cellulitis in adults. http://www.acutemed.co.uk/docs/Cellulitis%20guidelines, %20CREST, %2005.pdf June 2005. [: www.crestni.org.uk ISBN 1-903982-12-X].
19. Donner A, Piaggio G, Villar J. Statistical methods for the meta analysis of cluster randomization trials. Statistical Methods in Medical Research 2001;10(5):325-38.
20. Dryden MS. Complicated skin and soft tissue infection. Journal of Antimicrobial Chemotherapy 2010;65(Suppl 3):iii35-iii44.
21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by simple graphical test. BMJ 1997;315(7109):629-34.
22. Ellis Simonsen SM, van Orman ER, Hatch BE, Jones SS, Gren LH, Hegann KT, et al.Cellulitis incidence in a defined population. Epidemiology and Infection 2006;134(2):293-9.
23. Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al.Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clinical Infectious Diseases 2003;36(5):592-8.
24. Ernst E, Sieder CH, März R. Adverse drug reactions to herbal and synthetic expectorants. International Journal of Risk and Safety in Medicine 1995;7:219-25.
25. Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA, et al.Managing skin and soft tissue infections: expert panel recommendations on key decision points. Journal of Antimicrobial Chemotherapy 2003;52 (Suppl 1):i3-i17.
26. Food, Drug Administration (FDA). Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment. Guidance for Industry: Center for Drug Evaluation and Research (CDER). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071185.pdf%201998. October 2013.
27. Fritsche TR, Sader HS, Jones RN. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004). Diagnostic Microbiology and Infectious Disease 2007;58(1):19-26.
28. Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs 2003;63(14):1459-80.
29. Gold WL, Salit IE. Aeromonas hydrophila infections of skin and soft tissue: report of 11 cases and review. Clinical Infectious Diseases 1993;16(1):69-74.
30. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005 Feb;365(9459):579-87.
31. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. The Cochrane Collaboration.
32. Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. The Cochrane Collaboration.
33. Huang L, Ye WH. Primary research for pharmacology of compound baikal skullcap root and the elements of it. China Journal of Chinese Materia Medica 1990;15(2):115-9.
34. Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest 2007;131(6):1865-9.
35. Kim SH, Shin DS, Oh MN, Chung SC, Lee JS, Oh KB. Inhibition of the bacterial surface protein anchoring transpeptidase sortase by isoquinoline alkaloids. Bioscience, Biotechnology and Biochemistry 2004;68(2):421-4.
36. Kluytmans-Vandenbergh MF, Kluytmans JA. Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives. Clinical Microbiology and Infection 2006;12 (Suppl 1):9-15.
37. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, et al.Epidemiology of severe Streptococcus pyogenes disease in Europe. Journal of Clinical Microbiology 2008;46(7):2359-67.
38. Leach FS. Anti-microbial properties of Scutellaria baicalensis and Coptis chinensis, two traditional Chinese medicines. Bioscience Horizons 2011 Jun;4(2):119-27.
39. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
40. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al.The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Medicine 2009;6:e1000100.
41. Lin JL, Ho YS. Flavonoid-induced acute nephropathy. American Journal of Kidney Diseases 1994;23:433-40.
42. Liu CS, Cham TM, Yang CH, Chang HW, Chen CH, Chuang LY. Antibacterial properties of Chinese herbal medicines against nosocomial antibiotic resistant strains of Pseudomonas aeruginosa in Taiwan. The American Journal of Chinese Medicine 2007;35(6):1047-9. [DOI: 10.1142/S0192415X07005508].
43. Liu CC, Chen XJ, Fang XW. Essentials of Traditional Chinese Medicine. In: Xu XC editor(s). The English-Chinese Encyclopedia of Practical Traditional Chinese Medicine. Vol. 1, Beijing: Higher Education Press of China, 1991:1-4.
44. Liu JP, Yang M, Liu YX, Wei ML, Grimsgaard S. Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD004116.pub2].
45. Maechel H. Cirkan-induced chronic diarrhea [Diarrhée chronique secondaire au Cirkan]. Gastroentérologie Clinique et Biologique 1992;16(4):373-9.
46. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagnostic Microbiology and Infectious Disease 2007;57(1):7-13.
47. Morris A. Cellulitis and erysipelas. In: BMJ editorial board editor(s). Clinical Evidence. London: BMJ Books, 2001:1146-9.
48. Neil A, Silagy C. Garlic, its cardioprotective properties. Current Opinion in Lipidology 1994;5:6-10.
49. Nichols RL, Flormana S. Clinical presentations of soft-tissue infections and surgical site infections. Clinical Infectious Diseases 2001;33(Suppl 2):S84-S93.
50. Purcell K, Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital. Archives of Pediatrics and Adolescent Medicine 2005;159(10):980-5.
51. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
52. Romano A, Caubet JC. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis. The Journal of Allergy & Clinical Immunology in Practice 2014;2(1):3-12.
53. Société Française de Dermatologie (SFD). Erysipelas and necrotizing fasciitis [Erysipele et fasiite necrosante: prise en charge]. Annales de Dermatologie et de Vénéréologie 2001;128:463-82.
54. Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http://www.sign.ac.uk/methodology/filters.html#random (accessed May 2014).
55. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ, et al.Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clinical Infectious Diseases 2005;41(10):1373-406.
56. Turnidge J, Christiansen K. Antibiotic use and resistance proving the obvious. Lancet 2005;365(9459):548-9.
57. United Kingdom Department of Health (UKDOH). Hospital Episode Statistics 2001. http://www.statistics.gov.uk (accessed June 2003).
58. Vickers A, Zollman C. ABC of complementary medicine: herbal medicine. BMJ 1999;319(7216):1050-3.
59. Wang JH, Su F. A brief introduction to Traditional Chinese Medicine. In: Jiehua Wang, Feng Su editor(s). Essential English of Traditional Chinese Medicine. 1st Edition. Vol. 1, Zhengzhou: Henan Science & Technology Publishing House, 2008 Jun:1-4.
60. Westphal J, Hörning M, Leonhardt K. Phytotherapy in functional upper abdominal complaints. Phytomedicine 1996;2:285-91.
61. Wilkie A, Cordess CH. Ginseng: a root just like a carrot?. Journal of the Royal Society of Medicine 1994;87:594-6.
62. Xia J, Li C. Problem solving skills for schizophrenia. Cochrane Database of Systematic Reviews 2010, Issue 5. [DOI: 10.1002/14651858.CD006365.pub2].
63. Zhai YC. Scope and Feature of Surgery of TCM. Surgery of Traditional Chinese Medicine. 1st Edition. Shanghai: Publishing House of Shanghai University of Traditional Chinese Medicine, 2002 Dec:1-2.
64. Zhou H, Lutterodt H, Cheng Z, Yu LL. Anti-inflammatory and antiproliferative activities of trifolirhizin, a flavonoid from Sophora flavescens roots. Journal of Agricultural and Food Chemistry 2009;57(11):4580-5.